Profile
Christopher Paul Blackwell is a former Chief Executive Officer of Vectura Group Ltd. He also served as an Executive Director at Scotia Pharmaceuticals Ltd. and as a Clinical Pharmacologist at GlaxoSmithKline Research & Development Ltd. Currently, he is a Non-Executive Director at AGI Therapeutics Plc.
He was also a Non-Executive Chairman at Nuformix Plc from 2018 to 2021.
He holds a doctorate degree from the University of Bath, which he received in 1988.
Christopher Paul Blackwell active positions
| Companies | Position | Start |
|---|---|---|
AGI Therapeutics Plc
AGI Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of differentiated drug products | Director/Board Member | 2007-04-10 |
Former positions of Christopher Paul Blackwell
| Companies | Position | End |
|---|---|---|
| NUFORMIX PLC | Chairman | 2021-02-09 |
| VECTURA GROUP | Chief Executive Officer | 2015-06-30 |
Scotia Pharmaceuticals Ltd.
Scotia Pharmaceuticals Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical products | Director/Board Member | - |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Corporate Officer/Principal | - |
GlaxoSmithKline Research & Development Ltd.
GlaxoSmithKline Research & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Functions as a commercial physical research company | Corporate Officer/Principal | - |
Training of Christopher Paul Blackwell
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Vectura Group Ltd.
Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures inhalation drugs and medical devices | Health Technology |
AGI Therapeutics Plc
AGI Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of differentiated drug products | Health Technology |
University of Bath
University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
GlaxoSmithKline Research & Development Ltd.
GlaxoSmithKline Research & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Functions as a commercial physical research company | Commercial Services |
Scotia Pharmaceuticals Ltd.
Scotia Pharmaceuticals Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Nuformix Plc
Nuformix Plc BiotechnologyHealth Technology Develops commercial technologies in pharmaceutical and biotechnology sector | Health Technology |
- Stock Market
- Insiders
- Christopher Paul Blackwell
















